NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 16 04:00PM ET
62.53
Dollar change
+2.06
Percentage change
3.41
%
IndexS&P 500 P/E14.94 EPS (ttm)4.19 Insider Own0.15% Shs Outstand1.27B Perf Week-6.63%
Market Cap79.10B Forward P/E8.89 EPS next Y7.03 Insider Trans-66.27% Shs Float1.26B Perf Month-8.78%
Income5.28B PEG1.05 EPS next Q1.47 Inst Own87.50% Short Float1.30% Perf Quarter-5.01%
Sales378.85B P/S0.21 EPS this Y12.55% Inst Trans3.24% Short Ratio1.58 Perf Half Y15.73%
Book/sh60.96 P/B1.03 EPS next Y15.32% ROA2.09% Short Interest16.43M Perf Year11.66%
Cash/sh10.05 P/C6.22 EPS next 5Y14.16% ROE7.00% 52W Range43.56 - 72.51 Perf YTD39.30%
Dividend Est.2.35 (3.76%) P/FCF13.31 EPS past 5Y-6.37% ROI3.51% 52W High-13.76% Beta0.54
Dividend TTM2.66 (4.25%) Quick Ratio0.63 Sales past 5Y7.79% Gross Margin14.02% 52W Low43.55% ATR (14)2.34
Dividend Ex-DateApr 22, 2025 Current Ratio0.82 EPS Y/Y TTM-26.54% Oper. Margin3.05% RSI (14)41.84 Volatility3.56% 3.04%
Employees300000 Debt/Eq1.06 Sales Y/Y TTM4.84% Profit Margin1.39% Recom1.77 Target Price79.13
Option/ShortYes / Yes LT Debt/Eq0.96 EPS Q/Q60.22% Payout72.76% Rel Volume1.03 Prev Close60.47
Sales Surprise0.97% EPS Surprise32.15% Sales Q/Q6.96% EarningsMay 01 BMO Avg Volume10.42M Price62.53
SMA20-4.12% SMA50-5.83% SMA2005.42% Trades Volume10,764,492 Change3.41%
Date Action Analyst Rating Change Price Target Change
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Oct-04-24Upgrade TD Cowen Hold → Buy $59 → $85
May-30-24Initiated Robert W. Baird Neutral $61
May-07-24Downgrade TD Cowen Buy → Hold $99 → $59
May-02-24Downgrade UBS Buy → Neutral $85 → $60
Today 04:12PM
10:22AM
10:12AM
09:59AM
09:55AM
08:00AM Loading…
08:00AM
07:59AM
04:55AM
May-15-25 05:09PM
02:24PM
10:51AM
10:08AM
08:36AM
07:45AM
May-14-25 06:44PM
03:00PM Loading…
03:00PM
11:16AM
11:16AM
09:32AM
09:32AM
07:46AM
05:57AM
05:30AM
May-13-25 12:15PM
10:37AM
09:26AM
May-12-25 05:36PM
04:54PM
04:53PM
02:00PM
01:04PM Loading…
01:04PM
08:55AM
May-11-25 05:23PM
May-09-25 12:03PM
12:01PM
12:00PM
11:40AM
09:45AM
09:30AM
09:15AM
06:20AM
12:35AM
May-08-25 04:47PM
12:10PM
12:06PM
11:53AM
06:20AM
May-07-25 02:00PM
01:21PM
01:09PM
12:50PM
12:30PM
12:28PM
12:27PM
11:05AM
10:59AM
10:04AM
06:50AM
06:14AM
05:12AM
May-06-25 04:15PM
01:00PM
12:32PM
12:29PM
12:00PM
09:30AM
09:00AM
May-05-25 05:31PM
07:42AM
06:20AM
06:20AM
03:05AM
12:35AM
May-04-25 12:02PM
09:30AM
May-02-25 11:55AM
11:53AM
11:05AM
10:13AM
10:13AM
09:40AM
05:58AM
04:15AM
03:02AM
02:30AM
May-01-25 11:51PM
05:55PM
04:30PM
03:56PM
02:53PM
02:42PM
02:04PM
01:56PM
01:44PM
01:02PM
12:30PM
12:19PM
11:45AM
11:36AM
11:30AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBBINS LARRYDirectorMay 02 '25Sale67.862,276,068154,444,7589,670,731May 06 04:15 PM
ROBBINS LARRYDirectorMay 05 '25Sale67.411,323,93289,249,9458,346,799May 06 04:15 PM
ROBBINS LARRYDirectorMay 06 '25Sale66.67150,00010,000,7108,196,799May 06 04:15 PM
Shah Prem SEVP and Group PresidentMar 17 '25Option Exercise62.2184652,63043,190Mar 18 04:51 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Option Exercise62.217,513467,38415,907Mar 07 04:56 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Sale66.357,513498,4888,394Mar 07 04:56 PM
Clark James DavidOfficerMar 05 '25Proposed Sale66.357,513498,489Mar 05 05:25 PM
Mahoney Michael FDirectorFeb 18 '25Buy66.7030,0002,001,00039,356Feb 19 12:35 PM